Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Effects of nucleotides and nucleosides on coagulation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Prediction of bleeding by thromboelastography in ICU patients with haematological malignancy and severe sepsis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Valproic acid modulates platelet and coagulation function ex vivo

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Does whole blood coagulation analysis reflect developmental haemostasis?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Changes in thrombin generation in children after cardiac surgery and ex-vivo response to blood products and haemostatic agents

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Coagulation competence and fluid recruitment after moderate blood loss in young men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Nucleotides, including ADP, ATP and uridine triphosphate (UTP), are discharged profusely in the circulation during many pathological conditions including sepsis. Sepsis can cause hypotension and systemic activation of the coagulation and fibrinolytic systems in humans, which may cause disseminated intravascular coagulation. We investigated whether nucleotide-induced cardiovascular collapse as provoked by systemic infusion of adenosine, ADP, ATP, UTP and nitric oxide affected the haemostatic system as assessed by whole blood thromboelastography (TEG) analysis. Ten pigs received a randomized infusion of adenosine, ADP, ATP, UTP or nitric oxide until mean arterial pressure was reduced to approximately 40% of baseline simulating sepsis-induced hypotension. The effect of the infusions on the haemostatic system was evaluated by TEG, and endothelial release of tissue plasminogen activator and plasminogen activator inhibitor-1 was measured. In contrast to the other infused substrates, ADP caused a reduction in maximum amplitude (71.4 to 64.2; P <0.05), and reduced the angle, representing the thrombus formation (75.6 to 66.4; P <0.05), indicating hypocoagulation. Despite increases in t-PA release (2.1 to 2.7 ng/ml; P <0.05) and reductions in plasminogen activator inhibitor (33.9 +/- 10.9-17.8 +/- 4.4 ng/ml; P <0.05) no increased fibrinolysis was found when whole blood was evaluated by TEG. Circulating ADP induces hypocoagulation without signs of increased fibrinolysis as evaluated by TEG. The potential clinical significance of these findings should be investigated further because ADP discharged systemically may possibly contribute to the coagulopathy observed in severe sepsis.
OriginalsprogEngelsk
TidsskriftBlood Coagulation and Fibrinolysis
Vol/bind21
Udgave nummer5
Sider (fra-til)436-41
Antal sider6
ISSN0957-5235
DOI
StatusUdgivet - 1 jul. 2010

ID: 31029616